China approves clinical trials of Sinopharm's Omicron-specific jab

Name: China approves clinical trials of Sinopharm's Omicron-specific jab
Uploaded: 2022-04-27T21:30:59+03:00
Description: China approves clinical trials of Sinopharm's Omicron-specific jab

Published 27 April 2022